arrow
返回
V

Vincent Woo

Novo Nordisk

51H指数
195论文数
2.3W被引数
收录论文 48
发表时间
No Evidence of Increased Physical Activity-Related Hypoglycemia with Once-Weekly Insulin Icodec vs. Once-Daily Basal Insulin in Type 2 Diabetes-ONWARDS 1-5
err2024-06-14
err0
PREAI
errRiddell, Michael C.; Heller, Simon R.; Asong, Marisse; Carstensen, Lisbeth; Watt, Sara K.; Woo, Vincent C.
err分享
err收藏
Real-World Impact of Intermittently Scanned Continuous Glucose Monitoring on Hemoglobin A1c in People with Type 2 Diabetes in Canada That Use Basal Insulin-A Prospective Chart Review
err2023-06-20
err0
PREAI
errAbitbol, Alexander; Jain, Akshay B.; Tsoukas, Michael; Sigalas, John; Galm, Brandon P.; Lee, Jooho; Qureshy, Kamran S., Jr.; Collins, Caitlyn; Woo, Vincent C.
err分享
err收藏
Cardiovascular and kidney outcomes with canagliflozin according to type 2 diabetes treatment targets at baseline: Data from the CANVAS programme and CREDENCE
err2023-04-04
err2
errOAAI
errTsoukas, Michael A. A.; Woo, Vincent; Tobe, Sheldon W. W.; Slee, April; Rapattoni, Wally; Ang, Fernando G. G.; Seufert, Jochen; Neuen, Brendon L. L.; Arnott, Clare; Mahaffey, Kenneth W. W.; Wheeler, David C. C.
err分享
err收藏
The Resistance Exercise in Already Active Diabetic Individuals (READI) Randomized Clinical Trial
err2022-12-02
err1
errOAAI
errSigal, Ronald J.; Yardley, Jane E.; Perkins, Bruce A.; Riddell, Michael C.; Goldfield, Gary S.; Donovan, Lois; Malcolm, Janine; Hadjiyannakis, Stasia; Edwards, Alun L.; Gougeon, Rejeanne; Wells, George A.; Pacaud, Daniele; Woo, Vincent; Ford, Gordon T.; Coyle, Doug; Phillips, Penny; Doucette, Steve; Khandwala, Farah; Kenny, Glen P.
err分享
err收藏
Does diabetes affect the risk of involvement in a motor vehicle crash?
err2022-12-01
err0
PREAI
errDow, Jamie; Boucher, Lucie; Carr, David; Charlton, Judith L.; Hill, Linda; Koppel, Sjaan; Lilley, Roy; Marotolli, Richard; O'Neill, Desmond; Rapoport, Mark; Roy, Christine; Swirsky, Neil; Woo, Vincent; Gagne, Emmanuelle; Giroux, Claude; Rader, Tamara
err分享
err收藏
2022 Canadian Cardiovascular Society Guideline for Use of GLP-1 Receptor Agonists and SGLT2 Inhibitors for Cardiorenal Risk Reduction in Adults
err2022-08-01
err40
errOAAI
errMancini, G. B. John; O'Meara, Eileen; Zieroth, Shelley; Bernier, Mathieu; Cheng, Alice Y. Y.; Cherney, David Z., I; Connelly, Kim A.; Ezekowitz, Justin; Goldenberg, Ronald M.; Leiter, Lawrence A.; Nesrallah, Gihad; Paty, Breay W.; Piche, Marie-Eve; Senior, Peter; Sharma, Abhinav; Verma, Subodh; Woo, Vincent; Darras, Pol; Gregoire, Jean; Lonn, Eva; Stone, James A.; Yale, Jean-Francois; Yeung, Colin; Zimmerman, Deborah
err分享
err收藏
Cardiovascular (CV) and Kidney Outcomes with Canagliflozin (CANA) According to Type 2 Diabetes (T2D) Treatment Targets at Baseline (BL) : Data from the CANVAS Program and CREDENCE
err2022-06-01
err0
PREAI
errWoo, Vincent C.; Tsoukas, Michael; Tobe, Sheldon; Slee, April; Rapattoni, Wally; Ang, Fernando; Seufert, Jochen; Wheeler, David C.
err分享
err收藏
Remission of Type 2 Diabetes Following a Short-term Intensive Intervention With Insulin Glargine, Sitagliptin, and Metformin: Results of an Open-label Randomized Parallel-Design Trial
err2021-11-02
err10
errOAAI
errMcInnes, Natalia; Hall, Stephanie; Hramiak, Irene; Sigal, Ronald J.; Goldenberg, Ronald; Gupta, Nikhil; Rabasa-Lhoret, Remi; Braga, Manoela; Woo, Vincent; Sultan, Farah; Otto, Rose; Smith, Ada; Sherifali, Diana; Liu, Yan Yun; Gerstein, Hertzel C.
err分享
err收藏
Superior weight loss with once-weekly semaglutide versus other glucagon-like peptide-1 receptor agonists is independent of gastrointestinal adverse events
err2020-10-28
err38
errOAAI
errLingvay, Ildiko; Hansen, Thomas; Macura, Stanislava; Marre, Michel; Nauck, Michael A.; de la Rosa, Raymond; Woo, Vincent; Yildirim, Emre; Wilding, John
err分享
err收藏
Acute Kidney Injury Events in Patients With Type 2 Diaoetes Using SGLT2 Inhibitors versus Other Glucose-Lowering Drugs: A Retrospective Cohort Study
err2020-10-01
err46
PREAI
errRampersad, Christie; Kraut, Eyal; Whitlock, Reid H.; Komenda, Paul; Woo, Vincent; Rigatto, Claudio; Tangri, Navdeep
err分享
err收藏
Positioning sulphonylureas in a modern treatment algorithm for patients with type 2 diabetes: Expert opinion from a European consensus panel
err2020-07-05
err15
errOAAI
errConsoli, Agostino; Czupryniak, Leszek; Duarte, Rui; Jermendy, Gyorgy; Kautzky-Willer, Alexandra; Mathieu, Chantal; Melo, Miguel; Mosenzon, Ofri; Nobels, Frank; Papanas, Nikolaos; Roman, Gabriela; Schnell, Oliver; Sotiropoulos, Alexis; Stehouwer, Coen D. A.; Tack, Cees J.; Woo, Vincent; Fadini, Gian Paolo; Raz, Itamar
err分享
err收藏
Glycemic and Body Weight Responses to Oral Semaglutide in the PIONEER Trial Program
err2020-06-01
err2
PREAI
errDungan, Kathleen M.; Hertz, Christin L.; Mellbin, Linda; Nielsen, Morten Abildlund; Sorrig, Rasmus; Woo, Vincent C.; Vilsboll, Tina
err分享
err收藏
Remission of Type 2 Diabetes Following a Short-term Intervention With Insulin Glargine, Metformin, and Dapagliflozin
err2020-05-13
err17
PREAI
errMcInnes, Natalia; Hall, Stephanie; Sultan, Farah; Aronson, Ronnie; Hramiak, Irene; Harris, Stewart; Sigal, Ronald J.; Woo, Vincent; Liu, Yan Yun; Gerstein, Hertzel C.
err分享
err收藏
Hypertension Canada's 2020 Comprehensive Guidelines for the Prevention, Diagnosis, Risk Assessment, and Treatment of Hypertension in Adults and Children
err2020-05-01
err397
PREAI
errRabi, Doreen M.; McBrien, Kerry A.; Sapir-Pichhadze, Ruth; Nakhla, Meranda; Ahmed, Sofia B.; Dumanski, Sandra M.; Butalia, Sonia; Leung, Alexander A.; Harris, Kevin C.; Cloutier, Lyne; Zarnke, Kelly B.; Ruzicka, Marcel; Hiremath, Swapnil; Feldman, Ross D.; Tobe, Sheldon W.; Campbell, Tavis S.; Bacon, Simon L.; Nerenberg, Kara A.; Dresser, George K.; Fournier, Anne; Burgess, Ellen; Lindsay, Patrice; Rabkin, Simon W.; Prebtani, Ally P. H.; Grover, Steven; Honos, George; Alfonsi, Jeffrey E.; Arcand, JoAnne; Audibert, Francois; Benoit, Genevieve; Bittman, Jesse; Bolli, Peter; Cote, Anne-Marie; Dionne, Janis; Don-Wauchope, Andrew; Edwards, Cedric; Firoz, Tabassum; Gabor, Jonathan Y.; Gilbert, Richard E.; Gregoire, Jean C.; Gryn, Steven E.; Gupta, Milan; Hannah-Shmouni, Fady; Hegele, Robert A.; Herman, Robert J.; Hill, Michael D.; Howlett, Jonathan G.; Hundemer, Gregory L.; Jones, Charlotte; Kaczorowski, Janusz; Khan, Nadia A.; Kuyper, Laura M.; Lamarre-Cliche, Maxime; Lavoie, Kim L.; Leiter, Lawrence A.; Lewanczuk, Richard; Logan, Alexander G.; Magee, Laura A.; Mangat, Birinder K.; McFarlane, Philip A.; McLean, Donna; Michaud, Andre; Milot, Alain; Moe, Gordon W.; Penner, S. Brian; Pipe, Andrew; Poppe, Alexandre Y.; Rey, Evelyne; Roerecke, Michael; Schiffrin, Ernesto L.; Selby, Peter; Sharma, Mike; Shoamanesh, Ashkan; Sivapalan, Praveena; Townsend, Raymond R.; Tran, Karen; Trudeau, Luc; Tsuyuki, Ross T.; Vallee, Michel; Woo, Vincent; Bell, Alan D.; Daskalopoulou, Stella S.
err分享
err收藏
Are the cardiovascular and kidney benefits of empagliflozin influenced by baseline glucose-lowering therapy?
err2020-01-03
err66
PREAI
errInzucchi, Silvio E.; Fitchett, David; Jurisic-Erzen, Dubravka; Woo, Vincent; Hantel, Stefan; Janista, Christina; Kaspers, Stefan; George, Jyothis T.; Zinman, Bernard
err分享
err收藏
Efficacy of Semaglutide by Background Sodium-Glucose Cotransporter 2 Inhibitor: A Post Hoc Analysis of SUSTAIN 9
err2019-06-01
err0
PREAI
errZinman, Bernard; Bhosekar, Vaishali; Busch, Robert S.; Holst, Ingrid; Ludvik, Bernhard; Thrasher, James; Woo, Vincent C.; Philis-Tsimikas, Athena
err分享
err收藏